UBS AM’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $7.92K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $248K | Hold |
|
|||||
|
2022
Q2 | $238K | Hold |
|
|||||
|
2022
Q1 | $630K | Hold |
|
|||||
|
2021
Q4 | $558K | Hold |
|
|||||
|
2021
Q3 | $764K | Sell |
|
|||||
|
2021
Q2 | $1.32M | Buy |
|
|||||
|
2021
Q1 | $1.04M | Sell |
|
|||||
|
2020
Q4 | $1.07M | Buy |
|
|||||
|
2020
Q3 | $228K | Sell |
|
|||||
|
2020
Q2 | $195K | Sell |
|
|||||
|
2020
Q1 | $170K | Buy |
|
|||||
|
2019
Q4 | $188K | Sell |
|
|||||
|
2019
Q3 | $176K | Buy |
|
|||||
|
2019
Q2 | $216K | Buy |
|
|||||
|
2019
Q1 | $154K | Hold |
|
|||||
|
2018
Q4 | $138K | Hold |
|
|||||
|
2018
Q3 | $192K | Hold |
|
|||||
|
2018
Q2 | $170K | Sell |
|
|||||
|
2018
Q1 | $232K | Buy |
|
|||||
|
2017
Q4 | $105K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $156K | Sell |
|
|||||
|
2015
Q4 | $5.29M | Sell |
|
|||||
|
2015
Q3 | $4.83M | Hold |
|
|||||
|
2015
Q2 | $6.27M | Hold |
|
|||||
|
2015
Q1 | $6.98M | Hold |
|
|||||
|
2014
Q4 | $4.44M | Sell |
|
|||||
|
2014
Q3 | $3.85M | Buy |
|
|||||
|
2014
Q2 | $6.9M | Hold |
|
|||||
|
2014
Q1 | $7.37M | Hold |
|
|||||
|
2013
Q4 | $5.42M | Hold |
|
|||||
|
2013
Q3 | $6.8M | Buy |
|
|||||
|
2013
Q2 | $4.89M | Buy |
|